Search for: "ASTRAZENECA LP" Results 21 - 40 of 161
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2022, 6:00 am by Douglas J. Bucklin, Ph.D.
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
7 Aug 2011, 8:36 pm by Patent Docs
Hetero Drugs, Ltd., Unit III et al. 3:11-cv-04468; filed August 2, 2011 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
19 Mar 2010, 10:31 am by Dr. Shezad Malik
AstraZeneca Pharmaceuticals LP, MID L 1099 07 MT, Superior Court of New Jersey, Law Division, Middlesex County (New Brunswick). [read post]
3 Feb 2008, 9:47 pm
Astrazeneca Pharmaceuticals LP et al. 8:08-cv-00213; filed January 31, 2007 in the Middle District of Florida... [read post]
2 Apr 2009, 3:56 am
AstraZeneca LP Addressing the oft-raised (recently) issue of whether pharmaceutical sales representative employees are subject to the Outside Sales exemption, the District Court answered the question in the affirmative and granted Defendant’s Motion for Summary Judgment on the issue. [read post]
7 Jan 2008, 8:48 pm
Astrazeneca Pharmaceuticals LP et al. v. [read post]
9 Dec 2021, 7:15 am by Logan Murr
The decision relates to AstraZeneca AB’s and AstraZeneca Pharmaceuticals LP’s (collectively “AstraZeneca”) lawsuit against Mylan and Kindeva Drug Delivery LP (collectively “Mylan”) for infringing all claims of U.S. [read post]
26 Mar 2012, 5:00 am
District Judge Colleen Kollar-Kotelly for the District of Columbia dismissed without prejudice AstraZeneca Pharmaceuticals LP's ("AstraZeneca's") suit against FDA requesting declaratory and injunctive relief to prevent FDA from granting final approval to generic versions of Seroquel® (quetiapine fumarate) or Seroquel XR® (extended-release quetiapine fumarate). [read post]
24 Mar 2013, 8:01 pm by Patent Docs
Watson Laboratories, Inc. - Florida et al. 3:13-cv-01669; filed March 19, 2013 in the District Court of New Jersey • Plaintiffs: AstraZeneca AB; Aktiebolaget Hassle; AstraZeneca LP; KBI Inc.; KBI-E Inc. [read post]
10 Mar 2010, 6:05 am by John J. Cord
AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. [read post]
12 May 2017, 9:05 am by Tom Lamb
., AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca PLC, and AstraZeneca AB (collectively, Bristol-Myers/AstraZeneca), which developed, manufactured, and marketed the drugs, failed to adequately test the drugs and warn of their risks. [read post]
8 Dec 2016, 2:00 am by Linda O'Brien
Linda O'BrienCCHPurchasers of AstraZeneca LP’s heartburn medication Nexium were not entitled to a new trial to their challenge of “reverse payment” agreements between AstraZeneca and Ranbaxy Pharmaceuticals that allegedly blocked the entry of a generic version of the drug, the U.S. [read post]
9 Sep 2015, 6:11 am by Mary Jane Wilmoth
The Department of Justice announced settlements in the following False Claims Act lawsuits: AstraZeneca and Cephalon to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Program AstraZeneca LP has agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program, the Justice… [read post]
14 May 2013, 6:18 pm by Mark Zamora
 The lawsuits in the Nexium MDL claim that Nexium, created by manufacturer, AstraZeneca LP, causes side effects such as bone loss, which subsequently has resulted in fractures and similar symptoms. [read post]